These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 33299862

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
    Wang M, Li P, Wan R, Liu X.
    Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H, Li Y, Yuan Y, Li W, Zhang H, Zhang Z, Shi R, Liu M, Liu C, Chen C, Liu H, Chen J.
    BMC Cancer; 2020 Dec 04; 20(1):1189. PubMed ID: 33276757
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.
    Tu Z, Chen X, Tian T, Chen G, Huang M.
    Aging (Albany NY); 2021 Feb 26; 13(5):7397-7415. PubMed ID: 33658396
    [Abstract] [Full Text] [Related]

  • 11. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z, Shi R, Yuan K, Wang Y.
    Tumour Biol; 2016 Nov 26; 37(11):14979-14987. PubMed ID: 27655285
    [Abstract] [Full Text] [Related]

  • 12. Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer.
    Shi B, Behrens C, Vaghani V, Riquelme EM, Rodriguez-Canales J, Kadara H, Lin H, Lee J, Liu H, Wistuba I, Simon G.
    Cancer Med; 2019 Oct 26; 8(14):6383-6392. PubMed ID: 31456359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
    You Q, Guo H, Xu D.
    Drug Des Devel Ther; 2015 Oct 26; 9():5087-97. PubMed ID: 26366059
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
    Sun L, Zhou H, Yang Y, Chen J, Wang Y, She M, Li C.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32329507
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.